Angela De Lauretis captivated the audience with her presentation on our novel strategies for managing peri-mucositis and peri-implantitis. She addresses a common and complex clinical challenge with innovative solutions by combining effective implant debridement techniques with approaches to restore peri-health.
News
-
- 01/11/2024 0 CommentsSeminar on Biomaterial-Associated InfectionsRead More
On October 30th, 2024, Corticalis participated in a highly engaging seminar focused on biomaterial-associated infections, drawing a large audience of students and faculty members. The event featured international peri-implantitis experts Mariano Sanz, Lisa Heitz-Mayfield, and Mario Romandini, who shared their extensive research on the definitions, diagnostics, and cutting-edge interventions related to peri-implant diseases.
- 29/10/2024 0 CommentsFirst Clinical Advisory Board Meeting in OsloRead More
On October 27th, 2024, our first Clinical Advisory Board meeting took place in Holmenkollen, Oslo. This meeting brought together leading international experts in implant care and peri-implant health, including Mariano Sanz, Morten Klepp, Lisa Heitz-Mayfield, Leonardo Trombelli, and Fritz Heitz-Mayfield, along with the Corticalis AS team — Ståle Petter Lyngstadaas, Jan Eirik Ellingsen, Håvard Jostein Haugen, and Angela De Lauretis.
The meeting provided valuable insights, leading to several immediate improvements and establishing a clear path for future developments.
- 28/10/2024 0 CommentsCorticalis AS Showcases Innovative Research at EAO MilanRead More
We are delighted to announce that our industrial PhD student, Angela De Lauretis, presented her groundbreaking work at the prestigious EAO (European Association for Osseointegration) conference in Milan.
- 27/10/2024 0 CommentsAward-Winning Clinical Innovations in Implant DentistryRead More
Corticalis AS is proud to announce that Ingvild Nysæther has received the award for Best “Clinical Innovations in Implant Dentistry” at the EAO (European Association for Osseointegration) conference in Milan. This recognition was granted for the first clinical trial on our bone graft material, NuBone® Augment.
- 06/05/2024 0 CommentsNew PhD thesis on our bone graft materialsRead More
We’re delighted to announce that Minh has successfully defended his thesis, “The dynamics of bone augmentation with a TiO₂ graft material: Studies in challenging pre-clinical models.” His work focuses on our ceramic titanium dioxide scaffolds, which offer safer, more adaptable bone graft solutions for dental and orthopaedic treatments.